These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2237819)

  • 1. Bilirubin induces platelet aggregation.
    Moiny G; Thirion A; Deby C
    Thromb Res; 1990 Jul; 59(2):413-6. PubMed ID: 2237819
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulatory effects of vascular prostaglandins on the antiaggregatory activities of pentoxifylline acetylsalicylic acid combinations in vitro.
    Weithmann KU; Just M; Schlotte V; Seiffge D
    Vasa; 1989; 18(4):273-6. PubMed ID: 2514520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent effects of iloprost and alprostadil on platelets, blood pressure and fibrinolysis.
    Witt W; Baldus B
    Prog Clin Biol Res; 1989; 301():347-51. PubMed ID: 2477854
    [No Abstract]   [Full Text] [Related]  

  • 4. Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandins.
    Sinzinger H; O'Grady J; Fitscha P; Kaliman J
    N Engl J Med; 1984 Oct; 311(16):1052. PubMed ID: 6384781
    [No Abstract]   [Full Text] [Related]  

  • 5. DN.9693, a phosphodiesterase inhibitor, compared with prostaglandin E1 and prostacyclin in four platelet "function" tests.
    O'Brien JR; Etherington MD; Salmon GP
    Thromb Res; 1988 Apr; 50(1):237-41. PubMed ID: 2840751
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential effect of platelet inhibitors in normal and in hypercholesterolaemic subjects.
    Aviram M; Winterstein G; Brook JG
    Br J Clin Pharmacol; 1985 Jun; 19(6):715-9. PubMed ID: 2992558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further studies with 5E and 5Z analogues of PGI2 in platelets and vasculature.
    Oliva D; Giovanazzi S; Lograno M; Mongelli N; Corsini A; Fumagalli R; Nicosia S
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():172-5. PubMed ID: 2526466
    [No Abstract]   [Full Text] [Related]  

  • 8. Difficulty in detecting inhibition of platelet aggregation by the impedance method.
    Ingerman-Wojenski CM; Smith JB; Silver MJ
    Thromb Res; 1982 Nov; 28(3):427-32. PubMed ID: 6758188
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.
    Vargaftig BB; Lefort J; Chignard M; Benveniste J
    Eur J Pharmacol; 1980 Jul; 65(2-3):185-92. PubMed ID: 6995139
    [No Abstract]   [Full Text] [Related]  

  • 10. Specificity between the anti-aggregatory actions of prostacyclin, prostaglandin E1 and D2 on platelets.
    Whittle BJ; Hamid S; Lidbury P; Rosam AC
    Adv Exp Med Biol; 1985; 192():109-25. PubMed ID: 2871707
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of aspirin and PGE1 on the flow resistance of surface-induced microemboli in human blood.
    Merris CS; Solen KA
    Thromb Res; 1987 May; 46(3):503-8. PubMed ID: 3603438
    [No Abstract]   [Full Text] [Related]  

  • 12. Single-blind study of epoprostenol and 6-keto-prostaglandin E1 in man: effects of platelet aggregation and plasma renin.
    Miyamori I; Morise T; Yasuhara S; Takeda Y; Koshida H; Takeda R
    Br J Clin Pharmacol; 1985 Dec; 20(6):681-3. PubMed ID: 3912001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aspirin and prostaglandin E1 on in vitro thrombolysis with urokinase. Evidence for a possible role of inhibiting platelet activity in thrombolysis.
    Terres W; Beythien C; Kupper W; Bleifeld W
    Circulation; 1989 Jun; 79(6):1309-14. PubMed ID: 2720929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergic effect of cicaprost-clathrate and low-dose acetylsalicylic acid on platelet aggregation in man.
    Mahler M; Seifert W; Spiegel B; Staks T
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):446-7. PubMed ID: 1490775
    [No Abstract]   [Full Text] [Related]  

  • 15. Release of gelatinase A during platelet activation mediates aggregation.
    Sawicki G; Salas E; Murat J; Miszta-Lane H; Radomski MW
    Nature; 1997 Apr; 386(6625):616-9. PubMed ID: 9121586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of functional activity of thrombocytes in patients with "aspirin" bronchial asthma].
    Evsiukova EV
    Klin Med (Mosk); 1991 Sep; 69(9):26-9. PubMed ID: 1803142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of myocardial infarction in aspirin-treated unstable angina pectoris. Repeated studies of platelet aggregation and of the thromboxane-prostacyclin system].
    Shalaev SV
    Kardiologiia; 1992 Sep; 32(9-10):27-30. PubMed ID: 1287305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent inhibition of PAF-stimulated human platelets and polymorphonuclear leukocytes by the PGE1 analog OP-1206.
    Hecker G; König E; Ney P; Schrör K
    Prog Clin Biol Res; 1987; 242():317-22. PubMed ID: 2444988
    [No Abstract]   [Full Text] [Related]  

  • 19. A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
    Jørgensen KA; Dyerberg J; Stoffersen E
    Thromb Res; 1980 Sep; 19(6):877-81. PubMed ID: 6258262
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of drugs acting on platelet and neutrophil aggregation depending on their interaction.
    Akopov S; Grigorian M; Gabrielian E
    Methods Find Exp Clin Pharmacol; 1991 Nov; 13(9):591-4. PubMed ID: 1787765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.